Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Lidocaine hydrochloride 1% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 100mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 12mg/dose spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1.5% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.5% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 40mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 4% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+fluorescein sodium 4%/0.25% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+chlorhexidine 1%/0.25% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+chlorhexidine 2%/0.25% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine bitartrate 5mcg/lidocaine hydrochloride 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine bitartrate + lidocaine hydrochloride 10mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Domiphen bromide+lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine 0.5mg powder for intradermal injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
acétate de méthylprednisolone et chlorhydrate de lidocaïne 80/20 mg/2 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
acétate de méthylprednisolone et chlorhydrate de lidocaïne 40/10 mg/1 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 35 mg/g eye gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.5% injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.5% injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine 5mcg/lidocaine hydrochloride 15mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+glucose 0.2%/5% Polyfusor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.5% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+glucose 0.4%/5% Polyfusor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine 10mcg/lidocaine hydrochloride 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine 20mcg/lidocaine hydrochloride 20mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine 10mcg/lidocaine hydrochloride 20mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing glucose and lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1.5%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2%/epinephrine 1:500,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1% injection solution 2 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.5% injection solution 20 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1% injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1% injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1% injection solution 5 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2%/epinephrine 1:100,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+epinephrine 4% preservative free nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2% injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2% injection solution 5 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2% injection solution 2 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2% injection solution 20 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1%/epinephrine 1:100,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 5%/glucose 7.5% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.4%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.2%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.6%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 0.1%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride heavy 5% injection solution sterile ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 4% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 2% injection solution sterile ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Dextrose 7.5%ww/lidocaine hydrochloride 1.5%ww injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+epinephrine 4% conventional release nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+fluorescein sodium 4%/0.25% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% conventional release oromucosal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 20 mg/mL oromucosal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 5% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 5 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 5 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 10 mg/mL cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 10 mg/mL cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/1 gram conventional release gingival ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/1 gram conventional release gingival ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 100 milligram/5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 100 milligram/5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 40 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 40 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 200 milligram/20 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 200 milligram/20 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |